secwatch.observer — SEC 8-K summary
======================================

Issuer:     DBV Technologies S.A. (DBVT)
CIK:        0001613780
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001193125-26-206315
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DBV Technologies grants CEO 1.74M PSUs tied to FDA acceptance of Viaskin Peanut BLAs
--------------------------------------------------------------------------------

- 1,740,000 PSUs granted to CEO Daniel Tassé with grant date May 5, 2026.
- 50% vests upon FDA acceptance of BLA for ages 4-7; 50% for ages 1-3.
- Vesting requires continued employment through July 1, 2028; shares delivered in four installments through Jan 2030.
- If FDA accepts single BLA covering both age groups, all PSUs eligible to vest.
- Unvested PSUs cancelled if milestones not achieved by July 1, 2028.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613780/000119312526206315/0001193125-26-206315-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613780/000119312526206315/d150727d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-206315

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer